Search results for "ketamine"

showing 10 items of 38 documents

Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (

2017

Objectives: The objective of this study was to assess the efficacy of different anesthetic drug combinations on the Caspian Pond turtles (Mauremys caspica). Subjects and Methods: Three groups of the Caspian Pond turtles (n = 6) were anesthetized with three different drug combinations. Initially, a pilot study was conducted to determine the best drug doses for the anesthetization of the turtles, and according to these results, ketamine–diazepam (120 mg/kg ketamine hydrochloride [5%] and 2 mg/kg diazepam [5%]), ketamine–acepromazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg acepromazine [1%]), and ketamine–xylazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg xylazine [2%]) wer…

MaleXylazineDiazepamTime FactorsDose-Response Relationship DrugketamineShort CommunicationPilot ProjectsInjections IntramuscularTurtlesSex FactorsAnesthesia Recovery PeriodAnimalsFemaleAcepromazineAnestheticsMauremys caspicaIndian journal of pharmacology
researchProduct

Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (Mauremys caspica)

2017

Objectives: The objective of this study was to assess the efficacy of different anesthetic drug combinations on the Caspian Pond turtles (Mauremys caspica). Subjects and Methods: Three groups of the Caspian Pond turtles (n = 6) were anesthetized with three different drug combinations. Initially, a pilot study was conducted to determine the best drug doses for the anesthetization of the turtles, and according to these results, ketamine-diazepam (120 mg/kg ketamine hydrochloride [5%] and 2 mg/kg diazepam [5%]), ketamine-acepromazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg acepromazine [1%]), and ketamine-xylazine (120 mg/kg ketamine hydrochloride [5%] and 1 mg/kg xylazine [2%]) wer…

MaleXylazinePharmacologyDiazepamketamineDose-Response Relationship DrugTime FactorAnimalAnestheticSex FactorInjections IntramuscularTurtleAnesthesia Recovery PeriodFemalePilot ProjectPharmacology (medical)Mauremys caspicaAcepromazine
researchProduct

Lunasin-induced behavioural effects in mice: Focus on the dopaminergic system

2013

The present study for the first time is devoted to identify central effects of synthetic lunasin, a 43 amino acid peptide. A markedly expressed neuroleptic/cataleptic effect was observed at low (0.1-10 nmol/mouse) centrally administered doses in male C57Bl/6 mice. Lunasin considerably reduced the amphetamine hyperlocomotion but weakly apomorphine climbing behaviour. No influence on ketamine and bicuculline effects was observed. Binding assay studies demonstrated modest affinity of lunasin for the dopamine D₁ receptor (Ki=60 ± 15 μM). In a functional assay of cAMP accumulation on live cells lunasin antagonised apomorphine effect on D₁ receptor activation (pEC₅₀=6.1 ± 0.3), but had no effect …

Malemedicine.medical_specialtyApomorphineDopamine AgentsMotor ActivityPharmacologyBicucullineLunasinBehavioral NeuroscienceDopamine receptor D1SeizuresDopamineInternal medicineCyclic AMPmedicineAnimalsHumansGABA-A Receptor AntagonistsAmphetamineReceptorCatalepsyReceptors Dopamine D2ChemistryReceptors Dopamine D1DopaminergicBrainMice Inbred C57BLApomorphineAmphetamineHEK293 CellsEndocrinologyDopamine receptorSoybean ProteinsKetamineExcitatory Amino Acid AntagonistsCentral Nervous System Agentsmedicine.drugBehavioural Brain Research
researchProduct

Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.

2009

Background: Ketamine is a non-competitive antagonist at N-methyl-d-aspartate (NMDA) receptors and reduces neuronal injury after cerebral ischemia by blocking the excitotoxic effects of glutamate. However, cerebral regeneration by means of endogenous neurogenesis may be impaired with blockade of NMDA receptors. The effects of S(+) ketamine on post-ischemic neurogenesis are unknown and investigated in this study. Methods: Thirty-two male Sprague–Dawley rats were randomly assigned to the following treatment groups with intravenous S(+) ketamine anesthesia: S(+) ketamine 0.75 mg/kg/min with or without cerebral ischemia and S(+) ketamine 1.0 mg/kg/min with or without cerebral ischemia. Eight non…

Malemedicine.medical_specialtyNeurogenesisIschemiaHippocampusReceptors N-Methyl-D-AspartateBrain IschemiaRats Sprague-DawleyInternal medicinemedicineAnimalsKetamineDose-Response Relationship Drugbusiness.industryDentate gyrusNeurogenesisAntagonistGlutamate receptorGeneral Medicinemedicine.diseaseRatsAnesthesiology and Pain MedicineEndocrinologyAnesthesiaNMDA receptorKetaminebusinessExcitatory Amino Acid Antagonistsmedicine.drugActa anaesthesiologica Scandinavica
researchProduct

Epidural anesthesia: Simulated intravascular test dose with S(+) ketamine, lidocaine and adrenaline. A prospective, randomized, double blind and plac…

2015

Abstract Objective The use of a test dose in epidural anesthesia is a safety recommendation. However, specificity and sensitivity of the drugs used with this indication have not been conclusive. The main objective of this study was to compare the effectiveness and the adverse effects of a simulated intravascular test dose of adrenaline, lidocaine and S(+)-ketamine. Material and methods A prospective, randomized, double blinded, placebo controlled study was designed. ASA I patients scheduled for elective surgery were included. These were randomized to the following study groups: S(+)-ketamine 0.5 mg kg −1 (S+K group), 5% lidocaine 1.5 mg kg −1 (L5% group), adrenaline 15 μg (ADR group), and p…

Mean arterial pressureLidocainebusiness.industryPlacebo-controlled studyGeneral MedicineBlood pressureAnesthesiaHeart ratemedicineKetaminemedicine.symptombusinessAdverse effectTinnitusmedicine.drugRevista Española de Anestesiología y Reanimación (English Edition)
researchProduct

Evidence for an involvement of NMDA and non-NMDA receptors in synaptic excitation of phrenic motoneurons in the rabbit

1991

Abstract The action of endogenous excitatory amino acids on phrenic motoneurons was studied in anesthetized, vagotomized, paralyzed and artificially ventilated rabbits. The NMDA receptor antagonists APV and ketamine, as well as the non-NMDA receptor antagonists GAMS and DNQX were administered by microinjection into the ventral horn of the spinal segments C3-C5. Injection of each antagonist resulted in a reversible reduction of the phrenic nerve activity. Results suggest an important function of endogenous excitatory amino acids in the excitation of phrenic motneurons. NMDA as well as non-NMDA receptors are involved. The functional role of both receptor types in bulbospinal neurotransmission…

MicroinjectionsGlutamineNeurotransmissionBiologyReceptors N-Methyl-D-Aspartatechemistry.chemical_compoundQuinoxalinesmedicineDNQXAnimalsReceptorMicroinjectionPhrenic nerveMotor NeuronsRespirationGeneral NeuroscienceGlutamate receptorMotor neuronmusculoskeletal systemPhrenic Nervemedicine.anatomical_structure2-Amino-5-phosphonovalerateSpinal Cordnervous systemchemistrySynapsesNMDA receptorKetamineRabbitsNeuroscienceNeuroscience Letters
researchProduct

Topical amitriptyline and ketamine for the treatment of neuropathic pain.

2015

A neuropathy is a disturbance of function or pathological change in nerves. In some cases, peripheral neuropathic pain may occur due to a lesion or disease of the peripheral somatosensory nervous system. Efficacy of different agents for peripheral neuropathic pain conditions is less than optimal. The administration of topical analgesics might be an option, due to the potential of reduced adverse effects and increased patient compliance. There is major interest in compounding topical analgesics for peripheral neuropathic pain, but several challenges remain for this approach. Topical analgesics have the potential to be a valuable additional approach for the management of peripheral neuropathi…

Nervous systemAnalgesicsbusiness.industryGeneral NeuroscienceAdministration TopicalAmitriptylineDiseasePeripheralLesionmedicine.anatomical_structureAnesthesiaNeuropathic painmedicineHumansNeuralgiaPharmacology (medical)KetamineAmitriptylineKetamineNeurology (clinical)medicine.symptomAdverse effectbusinessmedicine.drugExpert review of neurotherapeutics
researchProduct

Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynor…

2021

Delayed onset of antidepressant action is a shortcoming in depression treatment. Ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) have emerged as promising rapid-acting antidepressants. However, their mechanism of action remains unknown. In this study, we first described the anxious and depression-prone inbred mouse strain, DBA/2J, as an animal model to assess the antidepressant-like effects of ketamine and HNK in vivo. To decode the molecular mechanisms mediating HNK's rapid antidepressant effects, a longitudinal cerebrospinal fluid (CSF) proteome profiling of its acute and sustained effects was conducted using an unbiased, hypothesis-free mass spectrometry-based proteomics app…

ProteomicsNeurophysiology and neuropsychologyanimal structuresHydroxynorketaminePhysiologyGlucocorticoid receptor signalingAntidepressantCSFNeurosciences. Biological psychiatry. NeuropsychiatryBiologyPharmacologyProteomicsBiochemistryCellular and Molecular NeuroscienceEndocrinologyGlucocorticoid receptorNeurotrophic factorsmedicineOriginal Research ArticleKetamine ; CSF ; Antidepressant ; (2R6R)-Hydroxynorketamine ; Glucocorticoid receptor signaling ; ProteomicsRC346-429Molecular BiologyPI3K/AKT/mTOR pathwayEndocrine and Autonomic SystemsQP351-495Mechanism of action(2R6R)-Hydroxynorketamineembryonic structuresAntidepressantKetamineNeurology. Diseases of the nervous systemmedicine.symptomSignal transductionRC321-571Neurobiology of Stress
researchProduct

Continuous Theta-Burst Stimulation Intensity Dependently Facilitates Motor-Evoked Potentials Following Focal Electrical Stimulation of the Rat Motor …

2020

Although theta-burst stimulation (TBS) is known to differentially modify motor cortical excitability according to stimulus conditions in humans, whether similar effects can be seen in animals, in particular rats, remains to be defined. Given the importance of experimental rat models for humans, this study explored this stimulation paradigm in rats. Specifically, this study aimed to explore corticospinal excitability after TBS in anesthetized animals to confirm its comparability with human results. Both inhibition-facilitation configurations using paired electrical stimulation protocols and the effects of the TBS paradigm on motor-evoked potentials (MEPs) in rat descending motor pathways wer…

Xylazine0301 basic medicinecorticospinal tractintracortical inhibitionMidazolamCognitive NeurosciencePyramidal TractsNeuroscience (miscellaneous)StimulationStimulus (physiology)lcsh:RC321-57103 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineAnimalsHypnotics and SedativesMedicineKetamineelectrical stimulationlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal Researchtheta burst stimulationbusiness.industryInterstimulus intervalMotor CortexNeural InhibitionMedetomidineEvoked Potentials MotorMedetomidineElectric StimulationSensory SystemsRats030104 developmental biologymedicine.anatomical_structureButorphanolModels AnimalCorticospinal tractFacilitationKetaminebusinessNeuroscience030217 neurology & neurosurgerymotor-evoked potentialsintracortical facilitationNeuroscienceMotor cortexmedicine.drugFrontiers in Neural Circuits
researchProduct

Spinal analgesia for advanced cancer patients: An update

2011

In the nineties, spinal analgesia has been described as an useful means to control pain in advanced cancer patients. The aim of this review was to update this information with a systematic analysis of studies performed in the last 10 years. 27 papers pertinent with the topic selected for review were collected according to selection criteria. Few studies added further information on spinal analgesia in last decade. Despite a lack of a clinical evidence, spinal analgesia with a combination of opioids, principally morphine, and local anesthetics may allow to achieve analgesia in patients who had been intensively treated unsuccessfully with different trials of opioids. Some adjuvant drugs such …

Ziconotidebusiness.industryMEDLINECancerHematologymedicine.diseaseClonidineOncologyNeoplasmsAnesthesiamedicineMorphineHumansPain ManagementBetamethasoneKetamineAnalgesiabusinessCancer painInjections Spinalmedicine.drugCritical Reviews in Oncology/Hematology
researchProduct